CompanyGraph
Zhejiang Garden Bio-chemical High-tech Co., Ltd.
300401 · SZSE · China
hybiotech.comFinancials as of FY2025
At a glance
- Depends onMidstream position: 5 outgoing, 4 incoming connections
- ScaleMarket cap is $1.17B, above the global median of $1.15B
- FinancialsAltman Z-Score 3.4: safe zone
- Interpretations2 currently firing — 2
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
0.79%Below 5Y avg (0.92%)
Annual Rate
CNY 0.11Paid annual
Payout Ratio
24.6%Sustainable
Last Ex-Dividend
May 27, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
7.88BCNY1.17B · vs all stocks (USD)
Trailing P/E
33.83xRevenue (TTM)
1.29BCNY192.21M · vs all stocks (USD)
Profit Margin
21.27%52-Week Change
-7.30%vs all stocks
Market Capitalization
7.88BCNY1.17B · vs all stocks (USD)
Enterprise Value
9.08BCNY1.35B · vs all stocks (USD)
Trailing P/E
33.83xForward P/E
19.21xPrice to Sales (TTM)
6.55xPrice to Book (MRQ)
2.35xEnterprise to Revenue
7.02xEnterprise to EBITDA
17.24xGross Margin
48.87%Profit Margin
21.27%Operating Margin
25.12%Return on Assets (TTM)
3.70%Return on Equity (TTM)
7.95%Revenue (TTM)
1.29BCNY192.21M · vs all stocks (USD)
Revenue per Share (TTM)
2.35CNYUpdated Aug 19, 2026Quarterly Revenue Growth
34.40%Gross Profit (TTM)
639.25MCNY94.94M · vs all stocks (USD)
EBITDA (TTM)
358.85MCNY53.30M · vs all stocks (USD)
Net Income (TTM)
275.24MCNY40.88M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
25.60%Operating Cash Flow (TTM)
394.60MCNY58.61M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
-71.46MCNY-10.61M · vs all stocks (USD)
Trailing Annual Dividend Rate
0.1130CNYUpdated Aug 19, 2026Trailing Annual Dividend Yield
0.79%vs all stocks
5-Year Average Dividend Yield
0.92%vs all stocks
Payout Ratio
24.57%Minority Interest (Equity)
-10.13KCNYFY2025 · Dec 31, 2025Revenue
1.24BCNYFY2025 · Dec 31, 2025Cost of Goods Sold
549.06MCNYFY2025 · Dec 31, 2025Gross Profit
688.34MCNYFY2025 · Dec 31, 2025Operating Income
383.03MCNY56.89M · vs all stocks (USD)
Pre-tax Income
352.50MCNYFY2025 · Dec 31, 2025Income Tax Expense
47.64MCNYFY2025 · Dec 31, 2025Net Income
304.86MCNYFY2025 · Dec 31, 2025EBIT
384.97MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
571.39MCNYFY2025 · Dec 31, 2025Research & Development
65.46MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
149.90MCNYFY2025 · Dec 31, 2025Other Operating Expenses
25.40MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
8.24MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
32.47MCNYFY2025 · Dec 31, 2025EPS (Basic)
0.5600CNYFY2025 · Dec 31, 2025EPS (Diluted)
0.5100CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
544.40MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
544.40MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
304.86MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
6.32KCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
293.81MCNYFY2025 · Dec 31, 2025Free Cash Flow
-67.21MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
924.32MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
304.86MCNYFY2025 · Dec 31, 2025Other Non-cash Items
31.94MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-132.19MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
89.20MCNYFY2025 · Dec 31, 2025Capital Expenditures
-361.02MCNYFY2025 · Dec 31, 2025Purchase of Investments
-1.75BCNYFY2025 · Dec 31, 2025Sale of Investments
1.50BCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-610.16MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
1.13BCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-1.15BCNYFY2025 · Dec 31, 2025Common Dividends Paid
-92.15MCNYFY2025 · Dec 31, 2025Other Financing Charges
-90.00MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-208.25MCNYFY2025 · Dec 31, 2025Shares Outstanding
543.69MSharesUpdated Aug 19, 2026Float Shares
356.86MSharesUpdated Aug 19, 2026% Held by Insiders
34.21%vs all stocks
% Held by Institutions
2.05%vs all stocks
Total Cash (MRQ)
1.37BCNY203.14M · vs all stocks (USD)
Total Cash per Share (MRQ)
2.53CNYUpdated Aug 19, 2026Total Debt (MRQ)
1.84BCNY273.02M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.5141xCurrent Ratio (MRQ)
2.18xBook Value per Share (MRQ)
6.61CNYUpdated Aug 19, 2026Total Assets
5.78BCNY858.71M · vs all stocks (USD)
Total Current Assets
2.42BCNYFY2025 · Dec 31, 2025Total Liabilities
2.29BCNYFY2025 · Dec 31, 2025Total Non-current Assets
3.37BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
1.33BCNYFY2025 · Dec 31, 2025Total Current Liabilities
958.12MCNYFY2025 · Dec 31, 2025Cash
924.32MCNYFY2025 · Dec 31, 2025Cash Equivalents
108.11MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
1.03BCNYFY2025 · Dec 31, 2025Other Short-term Investments
301.22MCNYFY2025 · Dec 31, 2025Accounts Receivable
224.30MCNYFY2025 · Dec 31, 2025Inventory
750.08MCNYFY2025 · Dec 31, 2025Accounts Payable
328.88MCNYFY2025 · Dec 31, 2025Short-term Debt
491.43MCNYFY2025 · Dec 31, 2025Other Current Liabilities
2.04MCNYFY2025 · Dec 31, 2025Long-term Debt
1.26BCNYFY2025 · Dec 31, 2025Common Stock (Book)
543.47MCNYFY2025 · Dec 31, 2025Retained Earnings
2.50BCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
3.49BCNY518.20M · vs all stocks (USD)
52-Week Low
10.68CNYUpdated Aug 19, 202652-Week High
23.44CNYUpdated Aug 19, 202652-Week Change
-7.30%vs all stocks
50-Day MA
15.71CNYUpdated Aug 19, 2026200-Day MA
15.13CNYUpdated Aug 19, 2026Avg 10-Day Volume
37.44MSharesUpdated Aug 19, 2026Avg 30-Day Volume
34.18MSharesUpdated Aug 19, 2026Diluted EPS (TTM)
0.4600CNYUpdated Aug 19, 20262 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsWhere is this company structurally exposed?
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
It sits well below its peak, and the fall has been both deep and long.
Partial Recovery After Sharp Decline
A weak, thin-volume bounce inside a decline that is still far from recovered.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 3.4: safe zoneNotable
Altman Z-Score: 3.40
Supply Chain
Midstream position: 5 outgoing, 4 incoming connectionsNotable
Outgoing: 5.00Incoming: 4.00
Scale
Market cap is $1.17B, above the global median of $1.15BNotable
Market cap (USD): 1,170,856,894.536Global Median: 1,146,734,693.424
Companies that share the same coordination system — how they create, deliver, or capture value.
Tandem Diabetes Care Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Collegium Pharmaceutical Inc.
Tier 1ProductionApproval-Gated PipelineRule
Avanos Medical Inc.
Tier 1ProductionApproval-Gated PipelineRuleFlow
0009K0
Tier 1ProductionApproval-Gated PipelineRuleRisk
Glass House Brands Inc.
Tier 1ProductionApproval-Gated PipelineFlowRule
Guilin Sanjin Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Northeast Pharmaceutical Group Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Sanofi Consumer Healthcare Inc.
Tier 1ProductionApproval-Gated PipelineRuleFlow
BioGaia AB
Tier 1ProductionApproval-Gated PipelineRuleFlow
Guangzhou Wondfo Biotech Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Companies that share active interpretations — structural patterns currently present in both stocks.
Hwa Shin Co., Ltd.
2 interpretationsPartial Recovery After Sharp DeclineUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
Electric Connector Technology Co. Ltd.
2 interpretationsPartial Recovery After Sharp DeclineUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
Polyrocks Chemical Co., Ltd.
2 interpretationsPartial Recovery After Sharp DeclineUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated